Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26

BACKGROUND: Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor...

Descripción completa

Detalles Bibliográficos
Autores principales: Fletcher, Mary A., Zeng, Xiao R., Maher, Kevin, Levis, Silvina, Hurwitz, Barry, Antoni, Michael, Broderick, Gordon, Klimas, Nancy G.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876037/
https://www.ncbi.nlm.nih.gov/pubmed/20520837
http://dx.doi.org/10.1371/journal.pone.0010817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876037/
https://www.ncbi.nlm.nih.gov/pubmed/20520837
http://dx.doi.org/10.1371/journal.pone.0010817

Ejemplares similares